Wu and colleagues reported that upregulation of P-gp by pleiotrophin promotes doxorubicin resistance while knockdown of pleiotrophin enhances chemosensitivity in osteosarcoma cell lines [309]. This evidence concerns the gene PGP and osteosarcoma.